BUZZ-Amneal Pharma 公司有望加入标准普尔小型股指数，股价上涨

路透中文

Jan 28

BUZZ-Amneal Pharma 公司有望加入标准普尔小型股指数，股价上涨

1月28日 - ** Amneal Pharmaceuticals AMRX.O股价盘前上涨3.4%至14.30美元，该公司将于本周加入标准普尔小型股600指数.SPCY

** 标准普尔道琼斯指数公司（S&P Dow Jones Indices）周二晚些时候表示，仿制药和特殊处方药生产商AMRX将在1月30日（周五）开盘前取代TTM Technologies TTMI.O，进入标准普尔小型股600指数.SPCY。

** 印刷电路板生产商TTMI转入标准普尔中型股400指数.IDX，取代Civitas ResourcesCIVI.N，后者正在被SM EnergySM.N收购。

** Stephens分析师梅丽莎-罗伯茨（Melissa Roberts）在一份报告中指出，她预计被动型基金将需要购买约2290万股AMRX股票，相当于13天的隐含购买需求。

** 总部位于新泽西州布里奇沃特的 AMRX 拥有约 3.144 亿股流通股，市值约 40 亿美元。

** 截至周二收盘，股价在过去一年中上涨了约 60%

** 所有 5 位分析师都将该股评为 "买入"；根据 LSEG 数据，目标价中值为 15 美元

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2606127967"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2606127967\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2606127967?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-01-28 22:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2606127967","market":"hk","top_or_hot":-1,"title":"BUZZ-Amneal Pharma 公司有望加入标准普尔小型股指数，股价上涨","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Amneal Pharma 公司有望加入标准普尔小型股指数，股价上涨</title></head><body><p><span>1月28日</span><span> - </span>** Amneal Pharmaceuticals <span>AMRX.O</span>股价盘前上涨3.4%至14.30美元，该公司将于本周加入标准普尔小型股600指数<span>.SPCY</span></p><p>** 标准普尔道琼斯指数公司（S&amp;P Dow Jones Indices）周二晚些时候表示，仿制药和特殊处方药生产商AMRX将在1月30日（周五）开盘前取代TTM Technologies <span>TTMI.O</span>，进入标准普尔小型股600指数<span>.SPCY</span>。</p><p>** 印刷电路板生产商TTMI转入标准普尔中型股400指数<span>.IDX</span>，取代<a href=\"https://laohu8.com/S/CIVI\">Civitas Resources</a><span>CIVI.N</span>，后者正在被<a href=\"https://laohu8.com/S/SM\">SM Energy</a><span>SM.N</span>收购。</p><p>** Stephens分析师梅丽莎-罗伯茨（Melissa Roberts）在一份报告中指出，她预计被动型基金将需要购买约2290万股AMRX股票，相当于13天的隐含购买需求。</p><p>** 总部位于新泽西州布里奇<a href=\"https://laohu8.com/S/002886\">沃特</a>的 AMRX 拥有约 3.144 亿股流通股，市值约 40 亿美元。</p><p>** 截至周二收盘，股价在过去一年中上涨了约 60%</p><p>** 所有 5 位分析师都将该股评为 \"买入\"；根据 LSEG 数据，目标价中值为 15 美元</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Amneal Pharma 公司有望加入标准普尔小型股指数，股价上涨</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Amneal Pharma 公司有望加入标准普尔小型股指数，股价上涨\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2026-01-28 22:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Amneal Pharma 公司有望加入标准普尔小型股指数，股价上涨</title></head><body><p><span>1月28日</span><span> - </span>** Amneal Pharmaceuticals <span>AMRX.O</span>股价盘前上涨3.4%至14.30美元，该公司将于本周加入标准普尔小型股600指数<span>.SPCY</span></p><p>** 标准普尔道琼斯指数公司（S&amp;P Dow Jones Indices）周二晚些时候表示，仿制药和特殊处方药生产商AMRX将在1月30日（周五）开盘前取代TTM Technologies <span>TTMI.O</span>，进入标准普尔小型股600指数<span>.SPCY</span>。</p><p>** 印刷电路板生产商TTMI转入标准普尔中型股400指数<span>.IDX</span>，取代<a href=\"https://laohu8.com/S/CIVI\">Civitas Resources</a><span>CIVI.N</span>，后者正在被<a href=\"https://laohu8.com/S/SM\">SM Energy</a><span>SM.N</span>收购。</p><p>** Stephens分析师梅丽莎-罗伯茨（Melissa Roberts）在一份报告中指出，她预计被动型基金将需要购买约2290万股AMRX股票，相当于13天的隐含购买需求。</p><p>** 总部位于新泽西州布里奇<a href=\"https://laohu8.com/S/002886\">沃特</a>的 AMRX 拥有约 3.144 亿股流通股，市值约 40 亿美元。</p><p>** 截至周二收盘，股价在过去一年中上涨了约 60%</p><p>** 所有 5 位分析师都将该股评为 \"买入\"；根据 LSEG 数据，目标价中值为 15 美元</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AMRX","symbol_name":"Amneal Pharmaceuticals, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nL4S3YT1M4:1","article_id":"2606127967","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2606127967","pubTimestamp":1769609760,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Amneal Pharma 公司有望加入标准普尔小型股指数，股价上涨1月28日 - ** Amneal Pharmaceuticals AMRX.O股价盘前上涨3.4%至14.30美元，该公司将于本周加入标准普尔小型股600指数.SPCY** 标准普尔道琼斯指数公司周二晚些时候表示，仿制药和特殊处方药生产商AMRX将在1月30日（周五）开盘前取代TTM Technologies TTMI.O，进入标准普尔小型股600指数.SPCY。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"AMRX":"Amneal Pharmaceuticals, Inc.","TTMI":"TTM科技","CIVI":"Civitas Resources","BK4512":"苹果概念","SM":"SM Energy","BK4007":"制药","BK4145":"电子制造服务","BK4213":"石油与天然气的勘探与生产"},"translate_title":"BUZZ-Amneal Pharma Stock Rises as Inc. Looks to Join S&P Small Cap Index","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CIVI":0.9,"TTMI":0.9,"AMRX":0.9,"SM":0.9},"content_text":"BUZZ-Amneal Pharma 公司有望加入标准普尔小型股指数，股价上涨1月28日 - ** Amneal Pharmaceuticals AMRX.O股价盘前上涨3.4%至14.30美元，该公司将于本周加入标准普尔小型股600指数.SPCY** 标准普尔道琼斯指数公司（S&P Dow Jones Indices）周二晚些时候表示，仿制药和特殊处方药生产商AMRX将在1月30日（周五）开盘前取代TTM Technologies TTMI.O，进入标准普尔小型股600指数.SPCY。** 印刷电路板生产商TTMI转入标准普尔中型股400指数.IDX，取代Civitas ResourcesCIVI.N，后者正在被SM EnergySM.N收购。** Stephens分析师梅丽莎-罗伯茨（Melissa Roberts）在一份报告中指出，她预计被动型基金将需要购买约2290万股AMRX股票，相当于13天的隐含购买需求。** 总部位于新泽西州布里奇沃特的 AMRX 拥有约 3.144 亿股流通股，市值约 40 亿美元。** 截至周二收盘，股价在过去一年中上涨了约 60%** 所有 5 位分析师都将该股评为 \"买入\"；根据 LSEG 数据，目标价中值为 15 美元(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}